VEGF is major stimulator in model of choroidal neovascularization

Investigative Ophthalmology and Visual Science

Volumn 41, Issue 10, 2000, Pages 3158-3164

  Kwak, N ^a   Okamoto, N ^a   Wood, J M ^a   Campochiaro, P A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENISTEIN; PHOSPHOTRANSFERASE INHIBITOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN KINASE C; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRUCH MEMBRANE; CONTROLLED STUDY; DIABETIC RETINOPATHY; ENZYME ACTIVITY; HYPOXIA; MALE; MOUSE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; RETINOPATHY; SUBRETINAL NEOVASCULARIZATION;

ANIMALS; CHOROIDAL NEOVASCULARIZATION; ENDOTHELIAL GROWTH FACTORS; ENZYME INHIBITORS; GENISTEIN; LYMPHOKINES; MALE; MICE; MICE, INBRED C57BL; PHOSPHORYLATION; PHTHALAZINES; PLATELET-DERIVED GROWTH FACTOR; PROTEIN KINASE C; PYRIDINES; PYRIMIDINES; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033823756     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Blindness caused by diabetic retinopathy
2. Vision disorders in diabetes
3. Argon laser photocoagulation for neovascular maculopathy: Five year results from randomized clinical trials
4. The mode of development of the vascular system of the retina with some observations on its significance for certain retinal diseases
5. Retinal vascularization in health and disease
6. Midperipheral fundus involvement in diabetic retinopathy
7. Essential role of growth hormone in ischemia-induced retinal neovascularization
8. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated anglo-genesis
9. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo
10. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
11. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy
12. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
13. Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy
14. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases
15. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model
16. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization
17. Transgenic mice with increased expression of vascular endothelial growth factor in the retina: A new model of intraretinal and subretinal neovascularization
18. Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors
19. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins
20. Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy
21. Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization
22. Foveolar choroidal blood flow in age-related macular degeneration
23. Presumed macular choroidal watershed vascular filling choroidal neovascularization and systemic vascular disease in patients with age-related macular degeneration
24. Growth factor localization in choroidal neovascular membranes of age-related macular degeneration
25. Basic fibro-blast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes
26. Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor
27. Trans-differentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes
28. Expression of basic fibroblast growth factor mRNA in developing choroidal neovascularization
29. Vascular endothelial growth factor expression in choroidal neovascularization in rats
30. Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor
31. Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model
32. New anilino-phthalazines as potent and orally well absorbed inhibitors of the VEGF receptor tyrosine kinases useful as antagonists of tumor driven angiogenesis
33. A novel and potent inhibitor of VEGF receptor tyrosine kinases impairs VEGF-induced responses and tumor growth after oral administration
34. Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class
35. Inhibition of platelet-derived growth factor receptor tyrosine kinase inhibits vascular smooth muscle cell migration and proliferation
36. Genistein a dietary-derived inhibitor of in vitro angiogenesis
37. Basic fibroblast growth factor is neither necessary nor sufficient for the development of retinal neovascularization
38. Double-labeling for keratin and class III beta-tubulin within cultured retinal pigment epithelial cells: Comparison of chromogens to yield maximum resolution of two structural proteins within the same cell
39. Neovascularization after argon laser photocoagulation of macular lesions
40. Subretinal neovascularization developing after prophylactic argon laser photocoagulation of atrophic macular scars
41. Choroido-vitreal neovascularization after argon laser photocoagulation
42. Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells
43. Extracellular matrix-integrin binding modulates secretion of angiogenic growth factors by retinal pigmented epithelial cells
44. Selective neovascularization of the retinal pigment epithelium in rat photoreceptor degeneration in vivo
45. Hyperoxia causes decreased expression of vascular endothelial growth factor and endothelial cell apoptosis in adult retina
46. Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization